FUL:NYE-H. B. Fuller Company (USD)

EQUITY | Specialty Chemicals | New York Stock Exchange

Last Closing

USD 56.08

Change

+1.86 (+3.43)%

Market Cap

USD 2.42B

Volume

0.26M

Analyst Target

USD 50.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants, paints and other specialty chemical products. Its products include H.B. Fuller, Swift, Advantra, Clarity, Sesame, TEC, Foster, Rakoll and Rapidex.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
APD Air Products and Chemicals Inc

+4.72 (+1.75%)

USD 62.07B
DLY DoubleLine Yield Opportunities..

+0.05 (+0.33%)

USD 27.84B
PPG PPG Industries Inc

+2.18 (+1.98%)

USD 24.99B
LYB LyondellBasell Industries NV

+1.84 (+3.28%)

USD 18.04B
ALB Albemarle Corp

+1.18 (+2.05%)

USD 7.08B
AXTA Axalta Coating Systems Ltd

+0.90 (+2.91%)

USD 6.76B
ARKAF Arkema S.A

N/A

USD 5.63B
ESI Element Solutions Inc

+0.69 (+3.22%)

USD 5.42B
AVNT Avient Corp

+1.40 (+3.90%)

USD 3.42B
ASH Ashland Global Holdings Inc

+1.47 (+2.98%)

USD 2.51B

ETFs Containing FUL

PSCM Invesco S&P SmallCap Mate.. 0.00 % 0.29 %

+1.98 (+3.05%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.89% 38% F 12% F
Dividend Return 0.35% 14% F 12% F
Total Return -16.55% 38% F 12% F
Trailing 12 Months  
Capital Gain -28.46% 38% F 11% F
Dividend Return 0.87% 24% F 17% F
Total Return -27.59% 38% F 10% F
Trailing 5 Years  
Capital Gain 45.62% 70% C- 57% F
Dividend Return 9.47% 28% F 23% F
Total Return 55.09% 68% D+ 51% F
Average Annual (5 Year Horizon)  
Capital Gain 7.26% 71% C- 64% D
Dividend Return 8.22% 71% C- 59% D-
Total Return 0.96% 23% F 23% F
Risk Return Profile  
Volatility (Standard Deviation) 23.67% 67% D+ 41% F
Risk Adjusted Return 34.75% 71% C- 52% F
Market Capitalization 2.42B 63% D 72% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.30 22% 26%
Price/Book Ratio 1.66 30% 48%
Price / Cash Flow Ratio 9.86 48% 40%
Price/Free Cash Flow Ratio 10.69 48% 45%
Management Effectiveness  
Return on Equity 6.35% 63% 45%
Return on Invested Capital 7.85% 68% 57%
Return on Assets 4.72% 71% 72%
Debt to Equity Ratio 109.92% 32% 31%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.